SCHEMBL13626935

SCHEMBL13626935

Cc1cc(CC(N)C(=O)OCc2ccccc2)ccc1OCc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 9/20 0.60
FFAR1 O14842 4/20 0.48
LTA4H P09960 1/20 0.48
LAP3 P28838 1/20 0.48
RXRA P19793 1/20 0.48
RXRB P28702 1/20 0.48
RXRG P48443 1/20 0.48
MRGPRX4 Q96LA9 2/20 0.46
CD274 Q9NZQ7 2/20 0.45
PDCD1 Q15116 1/20 0.45
MAPT P10636 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
TACR1 P25103 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27406565 0.90 LTA4H (0.48) FFAR4FFAR1LTA4HLAP3RXRA
SCHEMBL12667394 0.90 MRGPRX4 (0.58) FFAR4FFAR1MRGPRX4CD274PDCD1
SCHEMBL19509037 0.88 LTA4H (0.51) FFAR4FFAR1LTA4HLAP3MAPT
SCHEMBL27406568 0.87 ALDH1A1 (0.49) LTA4HLAP3TACR1
SCHEMBL27406535 0.86 FFAR4 (0.44) FFAR4LTA4HLAP3CD274PDCD1
SCHEMBL2037257 0.85 POLB (0.50) FFAR4MAPTSMN1; SMN2L3MBTL1
SCHEMBL12643653 0.85 POLB (0.50) FFAR4MAPTSMN1; SMN2L3MBTL1
SCHEMBL27406548 0.85 SLC7A5 (0.50) LTA4HLAP3TDP1TACR1
SCHEMBL23086058 0.84 SLC7A5 (0.49) LTA4HLAP3TDP1TACR1
Hydrochloric Acid SCHEMBL29098553 0.82 LTA4H (0.48) LTA4HLAP3TDP1TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090286841-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. 2009-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286841-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS KIF5B, KIF2C, PLK1 FFAR4 4823/4885FFAR1 4743/4885LTA4H 4062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.